# Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia

> **NCT06211452** · PHASE3 · COMPLETED · sponsor: **Grupo Argentino de Tratamiento de la Leucemia Aguda** · enrollment: 258 (actual)

## Conditions studied

- AML
- Pediatric AML

## Interventions

- **DRUG:** ARM A: Active Comparator Drug
- **DRUG:** ARM B: Blocks Therapy Drug

## Key facts

- **NCT ID:** NCT06211452
- **Lead sponsor:** Grupo Argentino de Tratamiento de la Leucemia Aguda
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-08-01
- **Primary completion:** 2015-03-15
- **Final completion:** 2015-12-21
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2024-01-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06211452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06211452, "Comparison of Consolidation Strategies for Pediatric Patients With Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06211452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*